News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Parkinson-like neurotoxicity in female patients treated with Ide-cel
Photo from Samer Al Hadidi/X
Jul 30, 2024, 12:38

Parkinson-like neurotoxicity in female patients treated with Ide-cel

Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X, about a recent paper titled ”Parkinson-like neurotoxicity in female patients treated with idecabtagene-vicleucel” published in HemaSphere.

Authors: Audrey Couturier, Martine Escoffre, Frédérique Leh, Anne-Sophie Villoteau, Xavier Palard, Florence Le Jeune, Olivier Decaux, Thierry Lamy, Roch Houot.

Samer Al Hadidi

”Parkinson-like neurotoxicity in female patients treated with idecabtagene-vicleucel.

Nice summary tables of reported Parkinson-like neurotoxicity with BCMA CAR-T.

Such rare AEs occur with idecabtagene-vicleucel as well asciltacabtagene autoleucel – important for informed consent.”

Samer Al Hadidi

Source: Samer Al Hadidi/X

Anne-Sophie Villoteau asciltacabtagene autoleucel Audrey Couturier cancer cancer treatment Florence Le Jeune Frédérique Leh HemaSphere idecabtagene vicleucel Martine Escoffre Olivier Decaux OncoDaily Oncology Roch Houot Samer Al Hadidi Thierry Lamy UAMS Myeloma Center Xavier Palard
Special Coverage
Career
Dec 22, 2024, 11:42
OncoInfluencers to Follow on Social Media: Dr. Alejandro Aballay
Insight
Dec 22, 2024, 11:22
Omar Alhalabi: Antiangiogenesis and immune checkpoint blockade in urothelial cancer
Blog
Dec 22, 2024, 10:51
Gemma Peters: Heading into 2025 with hope
Science
Dec 22, 2024, 10:44
5 papers about Lung Cancer suggested by Stephen Liu
Science
Dec 22, 2024, 10:15
Dégi László Csaba: Thrilled to announce the new Lancet Oncology Policy Review analyzing NCCPs worldwide
Science
Dec 22, 2024, 10:13
Denis Horgan: Delayed Access to Personalized Medicine in the EU - What’s the Cost to Patients?
Blog
Dec 22, 2024, 10:12
Emad Shash: Honor to be among the newly elected council of the Egyptian Cancer Society
Science
Dec 22, 2024, 10:03
María Natalia Gandur Quiroga: Checkpoint inhibitors and Fc functions - key findings in oncology immunotherapy
Science
Dec 22, 2024, 10:00
Francesco Maura: CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma
Science
Dec 22, 2024, 09:59
CDK4/6 inhibitors: mechanisms of resistance and where to find them - Lorenzo Gerratana
Blog
Dec 22, 2024, 09:53
India's Oncology Testing Market Projected to Grow at 2% CAGR Through 2033: GlobalData
Dialogues
Dec 22, 2024, 09:40
Botensilimab: A Novel Anti-CTLA- 4 Therapy Effectively Treats Refractory Colorectal Cancers